• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO MEDICAL CORPORATION RUNTHROUGH NS; WIRE, GUIDE, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO MEDICAL CORPORATION RUNTHROUGH NS; WIRE, GUIDE, CATHETER Back to Search Results
Model Number 25-5211
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Perforation of Vessels (2135); Embolism/Embolus (4438)
Date of Event 10/17/2023
Type of Reportable Event Serious Injury
Event or Problem Description
The user facility reported that the runthrough device involved was used during a multiple vessel coronary percutaneous coronary intervention (pci) shockwave balloon angioplasty.A distal left anterior (lad) perforation was identified.Vessel perforation required embolization and surgical intervention.The procedure performed was a percutaneous coronary intervention (pci).There was no direct allegation that the reported device caused or contributed to patient injury and/or need for medical intervention.
 
Additional Manufacturer Narrative
D4: lot number: requested, unknown.D4: expiration date: unknown due to unknown lot number.D6a: implanted date: device was not implanted.D6b: explanted date: device was not explanted.H4: device manufacture date: unknown due to unknown lot number.Since the actual sample was not returned, detailed investigation could not be performed, and the cause of occurrence could not be clarified.Since the involved lot number was unknown, the investigation could not be performed.Since the involved lot number was unknown, the investigation could not be performed on past history files.Regarding the involved product code, there have been no events caused due to the manufacturing process in the past three years (december 2020 - november 2023).In order to clarify the cause of occurrence, we would like to ask for your cooperation in obtaining the actual sample in the future.Ashitaka factory has been making efforts in maintaining the quality of the product by performing following control.In the product assembling process, 100% visual inspection is performed to assure that there is no deformation in the coil.After the product assembling process, the outer diameter is measured on 100% basis to assure that there is no anomaly on it.After the product assembling process, the tip abutting resistance is measured on 100% basis to assure that there is no anomaly in the tip load.The dispensing amount of hydrophilic coating solution and the stirring time are controlled so that the coating amount and condition are managed to be uniform.In the shipping inspection, the tip sliding resistance value is measured per lot number basis to assure that there is no anomaly in its lubricity.The instructions for use (ifu) of this product includes the following statement: "if any resistance to the runthrough ns or the dilatation catheter is felt during manipulation or if the shape, behaviour or position of the guide wire's tip seems improper (e.G., the tip is trapped due to vessel spasm or some other cause, or the tip is folded), stop manipulating the guide wire (and the catheter), determine the cause carefully by fluoroscopy and take suitable remedial actions.Next, remove the guide wire slowly, without turning, and exchange it for a new one.Continuing guide wire or catheter manipulation in the said situations may result in damage to the vessel, damage to or separation of the guide wire's tip, and/or damage to the dilatation catheter." for the importer report please see (b)(4).(b)(4) (importer) registration no.(b)(4) is submitting this report on behalf of ashitaka factory of terumo corporation (manufacturer) registration no.9681834.
 
Additional Manufacturer Narrative
This report is being submitted as follow up no.1 to provide a correction to section d4: model number and catalog number.The production lot number was not provided by the user facility; therefore, the entire udi could not be provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RUNTHROUGH NS
Common Device Name
WIRE, GUIDE, CATHETER
Manufacturer (Section D)
TERUMO MEDICAL CORPORATION
950 elkton blvd.
elkton MD 21921
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, 418
JA   418
Manufacturer Contact
gina digioia
950 elkton blvd
elkton, MD 21921
4103927218
MDR Report Key18161511
Report Number9681834-2023-00231
Device Sequence Number15272744
Product Code DQX
UDI-Device Identifier34987350734700
UDI-Public34987350734700
Combination Product (Y/N)N
Initial Reporter StateMI
Initial Reporter CountryUS
PMA/510(K) Number
K063695
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,User Facility,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 11/17/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number25-5211
Device Catalogue NumberTW*AS418XHW
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/24/2023
Supplement Date Received by Manufacturer07/03/2024
Initial Report FDA Received Date11/17/2023
Supplement Report FDA Received Date07/16/2024
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other; Required Intervention;
Patient Age69 YR
Patient SexMale
-
-